Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease

A minimum of 158 adult subjects will be enrolled at up to a minimum of 20 sites in the U.S. and Europe. Data will be collected retrospectively and found within existing site files at Baseline, Treatment, Discharge, Pre-12-Month Follow-up, 12-Month Follow-Up, Subsequent Follow-Up Visits.

Inclusion criteria

• Patient treated with covered endovascular reconstruction of the aortic bifurcation (CERAB) procedure for aortoiliac occlusive disease (AIOD).
• Patient was implanted with the VBX Device in the aortic position during a CERAB procedure.
• Patient was treated with the CERAB procedure a minimum of 1 year before enrollment date.
• Age ≥18 years at the time of CERAB procedure.
• Obtain patient informed consent or waiver according to local Institutional Review Board (IRB)/Ethics Committee (EC) -

Exclusion criteria

• Patient with prior stenting in the aortic or common iliac artery at the time of CERAB procedure.
• Patient treated with concomitant chimney procedure at time of CERAB procedure (e.g., inferior mesenteric artery, renal artery).
• Participation in another drug or device investigational study at the time of the CERAB procedure date that can confound the study endpoints.

-